FOSL1 and esophageal cancer: DE VEGFA, FOSL1, MAOB, SDR16C5, RP11-58O9.2, RP11-667F14.1, and RP11-288A5.2 in hyperplastic tissues may serve as genetic targets for preventing stent restenosis in esophageal cancer.